Tenet Healthcare appoints CEO Dr. Saum Sutaria to additional role of Chairman of the Board of Directors

– USA, TX –  Tenet Healthcare Corporation (NYSE: THC) today announced the election of CEO Dr. Saum Sutaria (M.D.) to the additional position of Chairman of the Board of Directors, effective immediately, succeeding Senator Robert Kerrey, who will transition to Lead Director.

Dr. Sutaria has served as CEO since September 2021 and as a member of the Board of Directors since 2020. Formerly, he served as the COO.

“The appointment of Saum to Chairman is a testament to his steadfast leadership and commitment to Tenet Healthcare,” said Senator Robert Kerrey, Lead Director. “The Board looks forward to working closely with him in this new capacity to continue to create value for all our stakeholders.”

About Tenet Healthcare

Tenet Healthcare Corporation is a diversified healthcare services company headquartered in Dallas. Our care delivery network includes United Surgical Partners International, the largest ambulatory platform in the country, which operates or has ownership interests in more than 475 ambulatory surgery centers and surgical hospitals. We also operate 61 acute care and specialty hospitals, approximately 110 other outpatient facilities, a network of leading employed physicians, and a global business center in Manila, Philippines. Our Conifer Health Solutions subsidiary provides revenue cycle management and value-based care services to hospitals, health systems, physician practices, employers, and other clients. Across the Tenet enterprise, we are united by our mission to deliver quality, compassionate care in the communities we serve.

SOURCE: https://www.tenethealth.com/

- DisclaimerNews, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.